NIH supports Phase III trials to study how effective interventions are in large groups of people, comparing them to other standard or experimental interventions. We go deeper into these clinical trials and what you should know in our next edition of the NIH All About Grants podcast.
For decades, NIH has required valid analysis, also known as stratified analysis, to explore how well interventions work across sex/gender and race/ethnicity for all applicable clinical trials. After revising the policy last year, NIH now requires the findings from these stratified analyses to be reported on ClinicalTrials.gov after an applicable NIH-Defined Phase III clinical trial has completed. Wondering about how this impacts your research?
0 Comments
0 Comments